AGEN
Agenus Inc.
Halal Rating :
See Details
Last Price
$1.18
Last updated:
Market Cap
$538.99m
7D Change
-9.92%
1 Year Change
-45.27%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 7, 2023
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $25.3m | $79.7m | - | $19.65m | 0.00% | 24.65% |
| March 31, 2023 | $22.9m | $77.94m | - | $16.59m | 0.00% | 21.29% |
| Dec. 31, 2022 | $28.6m | $76.72m | - | $17.32m | 0.00% | 22.58% |
Company Impact
Help us evaluate Agenus Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.